I.B.N. Savio constantly innovates and/or develops the Group portfolio, autonomously, in cooperation with research institutes and other companies or by outsourcing.

Thanks to its multidisciplinary experience acquired in many years of activity, I.B.N. Savio  effectively supports the companies of the Group and its own Customers to obtain and maintain all the needed authorisations for the pharmaceutical products, medical devices and food supplements commercialisation, guaranteeing compliance to all applicable local, national and international regulations over time.

The attention to the scientific progress and the constant updating to the highest and strictest international standards, ensures a strong competitive advantage in the management of both strategic activities and operative steps throughout the whole lifecycle of products.

Pharmacovigilance is the set of activities aimed at continuously evaluating all information relating to the safety of medicines in order to ensure that, for all medicines, there is a favorable benefit/risk ratio for the population.

In line with this general definition, the main objectives of Pharmacovigilance are:

• Promote and protect public health by improving the use of medicines through the detection, evaluation, understanding and prevention of side effects or any other problems related to the medicine.
• Promote the safe and effective use of medicines through timely communication of medicine safety information to healthcare professionals, patients and the public.

For any reports, see the methods reported on the "Pharmacovigilance" page.

I.B.N. Savio takes care of the distribution of all the products belonging to the companies of the Group to the whole Wholesalers/Pharmacies/Hospitals supply chain on the national territory. To do this, I.B.N. Savio uses highly qualified logistic partners, able to assure the respect of the good storage and distribution practices in order to guarantee the absolute quality of its products for their whole shelf life.